Provided by Tiger Trade Technology Pte. Ltd.

Nexalin Technology, Inc.

3.63
-0.4800-11.68%
Post-market: 3.750.1200+3.31%19:56 EDT
Volume:68.18K
Turnover:254.03K
Market Cap:3.81M
PE:-0.26
High:3.95
Open:3.95
Low:3.50
Close:4.11
52wk High:50.70
52wk Low:3.50
Shares:1.05M
Float Shares:844.70K
Volume Ratio:0.15
T/O Rate:8.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.8684
EPS(LYR):-15.0475
ROE:-240.25%
ROA:-119.22%
PB:2.50
PE(LYR):-0.24

Loading ...

Nexalin Technology Announces Reverse Stock Split

THOMSON REUTERS
·
Aug 27

Nexalin Technology - Approves 1-for-30 Reverse Stock Split

THOMSON REUTERS
·
Aug 27

Morgan Stanley Keeps Their Buy Rating on Nuix Ltd. (NXL)

TIPRANKS
·
Aug 26

Jefferies Remains a Buy on Nuix Ltd. (NXL)

TIPRANKS
·
Aug 26

Nuix (ASX:NXL) Shares Ask Whether Neo Growth Justifies Premium P/E

Simply Wall St.
·
Aug 25

Nexalin Technology Enters USD 1.17 Million Unsecured Note Financing with Institutional Investor

Reuters
·
Aug 22

Nexalin Technology Prices Registered Direct Offering of 2,419,355 Shares at $0.31 Each

Reuters
·
Aug 21

Nexalin Falls Below NASDAQ Stockholders’ Equity Minimum, Faces Delisting Risk

Reuters
·
Aug 17

Nexalin Q2 FY26 Net Loss Widens 42% to $2.24 Million; Revenue Drops 83% to $12,161

Reuters
·
Aug 13

Nexalin Technology Menggelar Rapat Tahunan Pemegang Saham; Kuorum Tercapai 63,2%

Reuters
·
Aug 12

Nexalin Technology Inc Expected to Post a Loss of 10 Cents a Share - Earnings Preview

Reuters
·
Jul 31

RBC Capital Keeps Their Buy Rating on Nuix Ltd. (NXL)

TIPRANKS
·
Jul 29

Nexalin Appeals NASDAQ Delisting Notice After Failing $1 Minimum Bid Requirement

Reuters
·
Jul 28

Nexalin Technology Announces Annual Shareholder Meeting

Reuters
·
Jun 30

Nexalin Technology investigator wins award for neurostimulation research

TIPRANKS
·
Jun 23

Nexalin Technology lowers shareholder meeting quorum requirement to one-third in bylaw overhaul

Reuters
·
Jun 18

Nexalin says open-label pilot trial data show 77.8% anxiety response with DIFS brain-stimulation device

Reuters
·
Jun 16

Nexalin Study Shows Strong Anxiety and Depression Response in Brazil Trial

MT Newswires Live
·
Jun 10

Nexalin Technology completes neurostimulation protocol trial

TIPRANKS
·
Jun 10

Nexalin reports 77.8% anxiety response rate in Brazil trial of DIFS neurostimulation device

Reuters
·
Jun 10